Table 1.
Patient characteristics of the model derivation population
| UCC-SMART (n = 8355) | |
|---|---|
| Male sex | 6198 (74%) |
| Age (years) | 61 ± 9 |
| Current smoker | 2504 (30%) |
| Body mass index (kg/m2) | 27 ± 4 |
| Systolic blood pressure (mmHg) | 139 ± 20 |
| Diabetes mellitus | 1467 (18%) |
| Established coronary artery disease | 5215 (62%) |
| Established peripheral artery disease | 1459 (17%) |
| Established cerebrovascular disease | 2424 (29%) |
| Established abdominal aortic aneurysm | 706 (8%) |
| Total cholesterol (mmol/L) | 4.6 (3.9–5.5) |
| HDL-cholesterol (mmol/L) | 1.2 (1.0–1.4) |
| LDL-cholesterol (mmol/L) | 2.7 (2.1–3.5) |
| Triglycerides (mmol/L) | 1.4 (1.0–2.0) |
| Estimated GFR (mL/min/1.73 m2) | 77 ± 18 |
| hsCRP (mg/dL) | 2.0 (1.0–4.4) |
| Statin | 5764 (69%) |
| Antiplatelet therapy or anticoagulants | 6494 (78%) |
| Event rate per 1000 person-yearsa | 24 |
All data in n (%), mean ± standard deviation, or median (interquartile range).
GFR, glomerular filtration rate (calculated with the Chronic Kidney Disease Epidemiology Collaboration formula); hsCRP, high-sensitivity C-reactive protein.
a
Event rate of fatal + non-fatal (myocardial infarction, stroke) events per 1000 person-years.